Publications by authors named "Jeremy Isaacs"

Claim this Profile
B
Biomarker-Driven Diagnosis in Neurocognitive Disorders: A Clinician's Perspective on the Risks of Reductionism.
Verónica Alheia Cabreira, Jeremy D Isaacs

Neurol Clin Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cut-points and gray zones: The challenges of integrating Alzheimer's disease plasma biomarkers into clinical practice.
Jemma Hazan, Kathy Y Liu, Jeremy D Isaacs, Robert Howard

Alzheimers Dement· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a diagnostic checklist to identify functional cognitive disorder versus other neurocognitive disorders.
Verónica Cabreira, Jane Alty, Sonja Antic, Rui Araujo, Selma Aybek, Jeremy Darryl Isaacs

BMJ Neurol Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives on the diagnosis and management of functional cognitive disorder: An international Delphi study.
Verónica Cabreira, Jane Alty, Sonja Antic, Rui Araújo, Selma Aybek, Jeremy Isaacs

Eur J Neurol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dementia diagnosis rates and the impact of ethnicity, rurality and deprivation.
Jemma Hazan, Kathy Y Liu, Jeremy D Isaacs, Naaheed Mukadam

Aging Ment Health· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in a Biological Definition of Alzheimer Disease.
Jemma Hazan, Kathy Y Liu, Harry Costello, Jeremy D Isaacs, Madhav Thambisetty

Neurology· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The promise of molecular science in brain health. What breakthroughs are anticipated in the next 20 years?
Atticus H Hainsworth, Thomas P Blackburn, Elizabeth M Bradshaw, Fanny M Elahi, Philip B Gorelick, Jeremy D Isaacs

Cereb Circ Cogn Behav· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating demand for potential disease-modifying therapies for Alzheimer's disease in the UK.
Axel A S Laurell, Ashwin V Venkataraman, Tatjana Schmidt, Marcella Montagnese, Christoph Mueller, Jeremy D Isaacs

Br J Psychiatry· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Argyrophilic grain disease and co-pathologies in an older patient with a rapidly progressive neuropsychiatric syndrome.
Camilla N Clark, Norman Poole, Jeremy D Isaacs, Andrew D MacKinnon, Philip Rich

Neuropathol Appl Neurobiol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mild cognitive impairment: not much harm; not much help.
Jeremy D Isaacs

BJPsych Open· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PDE5 inhibitor drugs for use in dementia.
Atticus H Hainsworth, Ottavio Arancio, Fanny M Elahi, Jeremy D Isaacs, Feixiong Cheng

Alzheimers Dement (N Y)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing the cognitive effects of tadalafil. Neuropsychological secondary outcomes from the PASTIS trial.
Mathilde Mh Pauls, Jessica Fish, Lauren R Binnie, Philip Benjamin, Shai Betteridge, Jeremy D Isaacs

Cereb Circ Cogn Behav· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Has COVID-19 affected dementia diagnosis rates in England?
Jemma Hazan, Kathy Y Liu, Jeremy D Isaacs, Alistair Burns, Robert Howard

Int J Geriatr Psychiatry· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional cognitive disorder affects reaction time, subjective mental effort and global metacognition.
Tiago Teodoro, Akihiro Koreki, Jiaying Chen, Jan Coebergh, Norman Poole, Jeremy D Isaacs

Brain· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in care between younger and older patients in the 2019 English national memory service audit.
Laura D Cook, Helen Souris, Jeremy D Isaacs

BJPsych Bull· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PASTIS trial: Testing tadalafil for possible use in vascular cognitive impairment.
Mathilde M H Pauls, Lauren R Binnie, Philip Benjamin, Shai Betteridge, Brian Clarke, Jeremy D Isaacs

Alzheimers Dement· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's disease: Have we opened the Golden Gate to disease-modifying therapy?
Jeremy D Isaacs

Cereb Circ Cogn Behav· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Test-retest reliability of arterial spin labelling for cerebral blood flow in older adults with small vessel disease.
Lauren R Binnie, Mathilde M H Pauls, Philip Benjamin, Mohani-Preet K Dhillon, Shai Betteridge, Jeremy D Isaacs

Transl Stroke Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vasculocentric Axonal NfH in Small Vessel Disease.
Adam Anad, Miriam K Barker, Jessica A Katanga, Konstantinos Arfanakis, Leslie R Bridges, Jeremy D Isaacs

J Neuropathol Exp Neurol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders?
Anders Wallin, Suvarna Alladi, Sandra E Black, Christopher Chen, Steven M Greenberg, Jeremy D Isaacs

Cereb Circ Cogn Behav· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: Functional cognitive disorder: dementia's blind spot.
Harriet A Ball, Laura McWhirter, Clive Ballard, Rohan Bhome, Daniel J Blackburn, Jeremy D Isaacs

Brain· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mild cognitive impairment: the Manchester consensus.
Ross A Dunne, Dag Aarsland, John T O'Brien, Clive Ballard, Sube Banerjee, Jeremy D Isaacs

Age Ageing· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers for dementia: too soon for routine clinical use.
Jeremy D Isaacs, Marianne Boenink

Lancet Neurol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional cognitive disorder: dementia's blind spot.
Harriet A Ball, Laura McWhirter, Clive Ballard, Rohan Bhome, Daniel J Blackburn, Jeremy D Isaacs

Brain· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DCTN1-related Parkinson-plus disorder (Perry syndrome).
Daniel Richardson, Meriel M McEntagart, Jeremy D Isaacs

Pract Neurol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis